Bnc Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Bnc Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$407.69 - $446.08 $2.2 Million - $2.41 Million	5,405 New	5,405 $2.26 Million
Q3 2023 Oct 25, 2023	BUY	$338.18 - $362.46 $70,679 - $75,754	209 Added 2.66%	8,070 $2.81 Million
Q2 2023 Jul 28, 2023	BUY	$314.42 - $351.91 $2.47 Million - $2.77 Million	7,861 New	7,861 $2.77 Million
Q4 2020 Mar 05, 2021	SELL	$207.01 - $276.09 $1,449 - $1,932	-7 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$255.65 - $303.1 $1,789 - $2,121	7 New	7 $2,000

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Bnc Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bnc Wealth Management, LLC with notifications on news.